{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:51Z","timestamp":1792785951739,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:00:00Z","timestamp":1608595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"name":"Mectizan Donation Program"},{"name":"Global Alliance for LF Elimination"},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP43922"],"award-info":[{"award-number":["OPP43922"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was established with the ambitious goal of eliminating LF as a public health problem. The remarkable success of the GPELF over the past 2 decades in carrying out its principal strategy of scaling up and scaling down mass drug administration has relied first on the development of a rigorous monitoring and evaluation (M&amp;E) framework and then the willingness of the World Health Organization and its community of partners to modify this framework in response to the practical experiences of national programmes. This flexibility was facilitated by the strong partnership that developed among researchers, LF programme managers and donors willing to support the necessary research agenda. This brief review summarizes the historical evolution of the GPELF M&amp;E strategies and highlights current research needed to achieve the elimination goal.<\/jats:p>","DOI":"10.1093\/inthealth\/ihaa084","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T15:13:05Z","timestamp":1602861185000},"page":"S65-S70","source":"Crossref","is-referenced-by-count":8,"title":["Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis"],"prefix":"10.1093","volume":"13","author":[{"given":"Patrick J","family":"Lammie","sequence":"first","affiliation":[{"name":"Division of Parasitic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M","family":"Gass","sequence":"additional","affiliation":[{"name":"NTD Support Center, Task Force for Global Health, 325 Swanton Way, Decatur, GA 30030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"King","sequence":"additional","affiliation":[{"name":"NTD Department, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Deming","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Addiss","sequence":"additional","affiliation":[{"name":"Division of Parasitic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Biswas","sequence":"additional","affiliation":[{"name":"NTD Department, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A","family":"Ottesen","sequence":"additional","affiliation":[{"name":"NTD Support Center, Task Force for Global Health, 325 Swanton Way, Decatur, GA 30030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Henderson","sequence":"additional","affiliation":[{"name":"NTD Support Center, Task Force for Global Health, 325 Swanton Way, Decatur, GA 30030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"issue":"6","key":"2021031906231686200_bib1","first-page":"491","article-title":"Strategies and tools for the control\/elimination of lymphatic filariasis","volume":"75","author":"Ottesen","year":"1997","journal-title":"Bull World Health Org"},{"key":"2021031906231686200_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0169-4758(97)01130-7","article-title":"The ICT filariasis test: a rapid format antigen test for diagnosis of bancroftian filariasis","volume":"13(10)","author":"Weil","year":"1997","journal-title":"Parasitol Today."},{"key":"2021031906231686200_bib3","article-title":"Generic framework for control, elimination and eradication of neglected tropical diseases","author":"World Health Organization Department of Control of Neglected Tropical Diseases"},{"issue":"12","key":"2021031906231686200_bib4","doi-asserted-by":"crossref","first-page":"e3328","DOI":"10.1371\/journal.pntd.0003328","article-title":"Global programme to eliminate lymphatic filariasis: the processes underlying programme success","volume":"8","author":"Ichimori","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021031906231686200_bib5","article-title":"Report of a WHO informal consultation on epidemiologic approaches to lymphatic filariasis elimination: initial assessment, monitoring, and certification","author":"World Health Organization Lymphatic Filariasis Elimination Programme"},{"key":"2021031906231686200_bib6","article-title":"Guidelines for certifying lymphatic filariasis elimination (including discussion of critical issues and rationale)","author":"World Health Organization Lymphatic Filariasis Elimination Programme"},{"key":"2021031906231686200_bib7","article-title":"Control of lymphatic filariasis in China","volume-title":"World Health Organization Regional Office for the Western Pacific","author":"World Health Organization Regional Office for the Western Pacific, Editorial Board of Control of Lymphatic Filariasis in China","year":"2003"},{"key":"2021031906231686200_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1590\/S1020-49892004001200013","article-title":"Assessing and monitoring vaccination coverage levels: lessons from the Americas","volume":"16(6)","author":"Dietz","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"2021031906231686200_bib9","article-title":"Preparing and implementing a national plan to eliminate lymphatic filariasis in countries where onchocerciasis in not co-endemic","author":"World Health Organization Department of Communicable Diseases Control, Prevention and Eradication"},{"key":"2021031906231686200_bib10","volume-title":"Monitoring and epidemiologic assessment of the programme to eliminate lymphatic filariasis at implementation unit level.","author":"World Health Organization Lymphatic Filariasis Elimination Programme","year":"2005"},{"issue":"1","key":"2021031906231686200_bib11","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1371\/journal.pntd.0001479","article-title":"A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis","volume":"6","author":"Gass","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"2021031906231686200_bib12","doi-asserted-by":"crossref","first-page":"e2584","DOI":"10.1371\/journal.pntd.0002584","article-title":"Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation","volume":"7","author":"Chu","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2021031906231686200_bib13","volume-title":"Monitoring and epidemiologic assessment of mass drug administration in the Global Programme to Eliminate Lymphatic Filariasis: a manual for national programmes. WHO\/HTM\/NTD\/PCT2011.4","author":"World Health Organization","year":"2011"},{"issue":"41","key":"2021031906231686200_bib14","first-page":"457","article-title":"Global programme to eliminate filariasis: progress report 2018","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"},{"key":"2021031906231686200_bib15","volume-title":"Assessing the epidemiology of soil transmitted helminths during a transmission assessment survey in the Global Programme for the Elimination of Lymphatic Filariasis. WHO\/HTM\/NTD\/PCT\/2015.2","author":"World Health Organization","year":"2011"},{"issue":"2","key":"2021031906231686200_bib16","doi-asserted-by":"crossref","first-page":"e0005387","DOI":"10.1371\/journal.pntd.0005387","article-title":"Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti","volume":"11","author":"Knipes","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"2021031906231686200_bib17","doi-asserted-by":"crossref","first-page":"e0005944","DOI":"10.1371\/journal.pntd.0005944","article-title":"The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: examples from Ethiopia and Tanzania","volume":"11","author":"Gass","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2021031906231686200_bib18","doi-asserted-by":"crossref","first-page":"e0006325","DOI":"10.1371\/journal.pntd.0006325","article-title":"Results of a confirmatory mapping tool for Lymphatic filariasis endemicity classification in areas where transmission was uncertain in Ethiopia","volume":"12","author":"Sime","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"2021031906231686200_bib19","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"Krentel","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2021031906231686200_bib20","volume-title":"Preventive chemotherapy: tools for improving the quality of reported data and information: a field manual for implementation","author":"World Health Organization Department of Neglected Tropical Diseases","year":"2019"},{"issue":"10","key":"2021031906231686200_bib21","doi-asserted-by":"crossref","first-page":"e0006066","DOI":"10.1371\/journal.pntd.0006066","article-title":"Reassessment of areas with persistent lymphatic filariasis nine years after cessation of mass drug administration in Sri Lanka","volume":"11","author":"Rao","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"2021031906231686200_bib22","doi-asserted-by":"crossref","first-page":"e0006583","DOI":"10.1371\/journal.pntd.0006583","article-title":"Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance \u2013 American Samoa, 2016","volume":"12","author":"Sheel","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"19","key":"2021031906231686200_bib23","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1706854","article-title":"A trial of a triple-drug treatment for lymphatic filariasis","volume":"379","author":"King","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"2021031906231686200_bib24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1473-3099(16)30467-4","article-title":"Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study","volume":"17","author":"Irvine","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021031906231686200_bib25","volume-title":"Guideline: alternative treatment regimens to eliminate lymphatic filariasis","author":"World Health Organization","year":"2017"},{"key":"2021031906231686200_bib26","volume-title":"Report of the first meeting of the WHO Diagnostic Technical Advisory Group for Neglected Tropical Diseases, Geneva, Switzerland, 30\u201331 October, 2019","author":"World Health Organization","year":"2020"}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/inthealth\/article-pdf\/13\/Supplement_1\/S65\/36643609\/ihaa084.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/inthealth\/article-pdf\/13\/Supplement_1\/S65\/36643609\/ihaa084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T02:23:45Z","timestamp":1616120625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article\/13\/Supplement_1\/S65\/6043673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,22]]},"references-count":26,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,12,22]]},"published-print":{"date-parts":[[2020,12,22]]}},"URL":"https:\/\/doi.org\/10.1093\/inthealth\/ihaa084","relation":{},"ISSN":["1876-3413","1876-3405"],"issn-type":[{"value":"1876-3413","type":"print"},{"value":"1876-3405","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,12,22]]}}}